{"entity":{"type":"insider","cik":"0001758838","url":"/insider/0001758838","json_url":"/insider/0001758838.json","name":"Partridge Andrew John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2021-07-15","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Partridge Andrew John","source":"filing","n_filings":3,"first_seen":"2021-07-15","last_seen":"2026-06-05"}],"transactions":[{"id":5933932,"accession":"0001628280-26-041356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-041356","line_url":"/filing/0001628280-26-041356#line-1","is_derivative":false,"issuer_cik":"0001699031","issuer_name":"GRAIL, Inc.","issuer_ticker":"GRAL","issuer_name_source":null,"issuer_url":"/issuer/0001699031","owner_cik":"0001758838","owner_name":"Partridge Andrew John","owner_url":"/insider/0001758838","role":"Officer (Chief Growth Officer)","officer_title":"Chief Growth Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1491.0,"shares_display":"1,491","price_per_share":61.08,"price_display":"61.08","price_state":"stated","total_value":91070.28,"total_display":"91,070.28","shares_owned_after":163738.0,"shares_owned_after_display":"163,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":6447245,"accession":"0001209191-22-008983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008983","line_url":"/filing/0001209191-22-008983#line-2","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001758838","owner_name":"Partridge Andrew John","owner_url":"/insider/0001758838","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":221.0,"shares_display":"221","price_per_share":36.3,"price_display":"36.30","price_state":"stated","total_value":8022.3,"total_display":"8,022.30","shares_owned_after":22078.0,"shares_owned_after_display":"22,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":5429269,"accession":"0001209191-21-046809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046809","line_url":"/filing/0001209191-21-046809#line-1","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001758838","owner_name":"Partridge Andrew John","owner_url":"/insider/0001758838","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1869.0,"shares_display":"1,869","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":139988.1,"total_display":"139,988.10","shares_owned_after":21767.0,"shares_owned_after_display":"21,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001699031","name":"GRAIL, Inc.","url":"/issuer/0001699031","role":"Officer (Chief Growth Officer)","n_filings":1,"first_seen":"2026-06-05","last_seen":"2026-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Officer (EVP & Chief Commercial Officer)","n_filings":2,"first_seen":"2021-07-15","last_seen":"2022-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001758838","retrieved_at":"2026-08-20T23:17:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}